Characterization of apolipoprotein C1 in hepatitis C virus infection and morphogenesis

Area of Science:

• Virology
• Molecular Biology
• Immunology

Background:

• Previous research indicated apolipoprotein C1 (apoC1) antibodies neutralized hepatitis C virus (HCV), suggesting apoC1's role in HCV.
• The specific function of apoC1 in the HCV life cycle remained experimentally unverified.

Purpose of the Study:

• To investigate the role of apoC1 in hepatitis C virus (HCV) infection and morphogenesis.
• To elucidate the functional relationship between apoC1 and apolipoprotein E (apoE) in HCV.

Main Methods:

• Utilized CRISPR/Cas9 gene editing to knock out the apoC1 gene in relevant cellular models.
• Assessed HCV infection and morphogenesis following apoC1 gene knockout.
• Examined the impact of apoC1 knockout on apoE expression.
• Investigated the combined effects of apoC1 knockout and apoE-specific small interfering RNAs (siRNAs).
• Tested the inhibitory effect of recombinant apoC1 protein on HCV infection.

Main Results:

• ApoC1 gene knockout led to a significant upregulation of apoE expression.
• ApoC1 gene knockout alone did not substantially alter HCV infection or morphogenesis, suggesting functional redundancy with apoE.
• Simultaneous apoC1 gene knockout and apoE knockdown potentiated the inhibition of HCV infection and/or morphogenesis.
• Recombinant apoC1 protein demonstrated potent inhibition of HCV infection.

Conclusions:

• ApoC1 and apoE exhibit redundant functions in hepatitis C virus (HCV) infection and morphogenesis.
• The interplay between apoC1 and apoE is crucial for understanding HCV viral dynamics.
• Targeting apoC1 or apoE could offer potential therapeutic strategies against HCV.